Yin Sun, Ph.D.

Yin Sun, Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 647
Rochester, NY 14642

Journal Articles

Showing all 29 journal articles available.

2016 Apr 1
Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Yeh S, Cai X, Chang C. "Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals." Cancer letters. 2016 Apr 1; 373(1):45-56. Epub 2016 Jan 19.
2016 Apr
Li W, Cohen A, Sun Y, Squires J, Braas D, Graeber TG, Du L, Li G, Li Z, Xu X, Chen X, Huang J. "The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma." Molecular cancer research : MCR. 2016 Apr; 14(4):344-53. Epub 2016 Feb 01.
2016 Apr
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C. "Targeting Androgen Receptor (AR)?IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression." Molecular cancer therapeutics. 2016 Apr; 15(4):731-42. Epub 2016 Mar 03.
2016 Mar 14
Zhai W, Sun Y, Jiang M, Wang M, Gasiewicz TA, Zheng J, Chang C. "Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2?/C-MYC axis under hypoxia." Oncogene. 2016 Mar 14; Epub 2016 Mar 14.
2016
Cui Y; Sun Y; Hu S; Luo J; Li L; Li X; Yeh SY; Jin J; Chang C. "Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemo-resistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signal". Oncogene. 2016; in press.
2015 Oct 13
Chen Y, Sun Y, Rao Q, Xu H, Li L, Chang C. "Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status." Oncotarget. 2015 Oct 13; 6(31):31203-15.
2015 Sep 17
Gan W, Dai X, Lunardi A, Li Z, Inuzuka H, Liu P, Varmeh S, Zhang J, Cheng L, Sun Y, Asara JM, Beck AH, Huang J, Pandolfi PP, Wei W. "SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression." Molecular cell. 2015 Sep 17; 59(6):917-30. Epub 2015 Sep 03.
2015 Jun 20
Qiu X, Zhu J, Sun Y, Fan K, Yang DR, Li G, Yang G, Chang C. "TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGF?R2/p-Smad3 signals." Oncotarget. 2015 Jun 20; 6(17):15397-409.
2015 Jun
Zhu J, Yang DR, Sun Y, Qiu X, Chang HC, Li G, Shan Y, Chang C. "TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression." Molecular cancer therapeutics. 2015 Jun; 14(6):1445-53. Epub 2015 Apr 01.
2015 Mar
Li Z, Sun Y, Chen X, Squires J, Nowroozizadeh B, Liang C, Huang J. "p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma." Molecular cancer research : MCR. 2015 Mar; 13(3):584-91. Epub 2014 Dec 15.
2013 May
Huang J, Wang JK, Sun Y. "Molecular pathology of prostate cancer revealed by next-generation sequencing: opportunities for genome-based personalized therapy." Current opinion in urology. 2013 May; 23(3):189-93.
2013 May
Li Z, Chen CJ, Wang JK, Hsia E, Li W, Squires J, Sun Y, Huang J. "Neuroendocrine differentiation of prostate cancer." Asian journal of andrology. 2013 May; 15(3):328-32. Epub 2013 Mar 18.
2012 Oct
Liu N, Tai S, Ding B, Thor RK, Bhuta S, Sun Y, Huang J. "Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis." Endocrine-related cancer. 2012 Oct; 19(5):711-23. Epub 2012 Sep 21.
2012 Jun
Chen H, Sun Y, Wu C, Magyar C, Li X, Cheng L, Yao JL, Shen S, Osunkoya AO, Liang C, Huang J. "Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway." Endocrine-related cancer. 2012 Jun; 19(3):321-31. Epub 2012 May 24.
2012 Jun
Tai S, Sun Y, Liu N, Ding B, Hsia E, Bhuta S, Thor RK, Damoiseaux R, Liang C, Huang J. "Combination of Rad001 (everolimus) and propachlor synergistically induces apoptosis through enhanced autophagy in prostate cancer cells." Molecular cancer therapeutics. 2012 Jun; 11(6):1320-31. Epub 2012 Apr 05.
2012 Apr 27
Ding B, Sun Y, Huang J. "Overexpression of SKI oncoprotein leads to p53 degradation through regulation of MDM2 protein sumoylation." The Journal of biological chemistry. 2012 Apr 27; 287(18):14621-30. Epub 2012 Mar 12.
2011 Nov
Tai S, Sun Y, Squires JM, Zhang H, Oh WK, Liang CZ, Huang J. "PC3 is a cell line characteristic of prostatic small cell carcinoma." The Prostate. 2011 Nov; 71(15):1668-79. Epub 2011 Mar 22.
2011 May 27
Sun Y, Perera J, Rubin BP, Huang J. "SYT-SSX1 (synovial sarcoma translocated) regulates PIASy ligase activity to cause overexpression of NCOA3 protein." The Journal of biological chemistry. 2011 May 27; 286(21):18623-32. Epub 2011 Mar 24.
2011 Jan
Sun Y, Huang JT. "Novel genetic loci associated with prostate cancer in the Japanese population." Asian journal of andrology. 2011 Jan; 13(1):120-1. Epub 2010 Oct 11.
2009
Sun Y, Niu J, Huang J. "Neuroendocrine differentiation in prostate cancer." American journal of translational research. 2009 1(2):148-62. Epub 2009 Feb 05.
2006 Feb 16
Sun Y, Gao D, Liu Y, Huang J, Lessnick S, Tanaka S. "IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1." Oncogene. 2006 Feb 16; 25(7):1042-52.
2001 Mar
Liu X, Sun Y, Weinberg RA, Lodish HF. "Ski/Sno and TGF-beta signaling." Cytokine & growth factor reviews. 2001 Mar; 12(1):1-8.
2000 Nov 30
Liu X, Sun Y, Ehrlich M, Lu T, Kloog Y, Weinberg RA, Lodish HF, Henis YI. "Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization." Oncogene. 2000 Nov 30; 19(51):5926-35.
2000 Apr 10
Liu X, Constantinescu SN, Sun Y, Bogan JS, Hirsch D, Weinberg RA, Lodish HF. "Generation of mammalian cells stably expressing multiple genes at predetermined levels." Analytical biochemistry. 2000 Apr 10; 280(1):20-8.
1999 Oct 26
Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. "SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling." Proceedings of the National Academy of Sciences of the United States of America. 1999 Oct 26; 96(22):12442-7.
1999 Oct
Sun Y, Liu X, Eaton EN, Lane WS, Lodish HF, Weinberg RA. "Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling." Molecular cell. 1999 Oct; 4(4):499-509.
1999 Feb 26
Wells RG, Gilboa L, Sun Y, Liu X, Henis YI, Lodish HF. "Transforming growth factor-beta induces formation of a dithiothreitol-resistant type I/Type II receptor complex in live cells." The Journal of biological chemistry. 1999 Feb 26; 274(9):5716-22.
1997 Sep 30
Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. "Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells." Proceedings of the National Academy of Sciences of the United States of America. 1997 Sep 30; 94(20):10669-74.
1995 Jul
Wanker EE, Sun Y, Savitz AJ, Meyer DI. "Functional characterization of the 180-kD ribosome receptor in vivo." The Journal of cell biology. 1995 Jul; 130(1):29-39.